Amgen gets approval for two plants

09/7/2005 | Reuters

Amgen said the FDA approved new manufacturing plants, with Amgen's Enbrel to be produced at a plant in Rhode Island and Neupogen and Neulasta to be manufactured at a new plant in Puerto Rico. The company also said it was building a second facility at the Puerto Rico site for production of its anemia drug, Epogen.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA